2003 Comment Letters

Below is a listing of AACC's most recent comment letters. If you have questions regarding AACC's positions, please contact AACC Government Affairs at (800) 892-1400.

11/13/03 AACC submitted comments to the OIG regarding its proposed rule on excessive payments for Medicare services
   
09/30/03 AACC wrote to Rep. Sensenbrenner in opposition to H.R.2613, the Public Access to Science Act
   
09/15/03 AACC wrote to CMS in support of its payment recommendations for new codes taking effect in FY04
   
07/30/03 AACC wrote to Medicare prescription drug conferees supporting the addition of cardiovascular and diabetes testing to the programs preventive services package
   
07/15/03 AACC submitted comments to the FDA regarding its draft guidance, entitled Multiplex Tests for Heritable DNA Markers, Mutations and Expressio Patterns; Draft Guidance for Industry and FDA Reviewers
   
05/27/03 AACC wrote to Senator DeWine endorsing S.1068, the Newborn Screening Saves Lives Act of 2003
   
05/05/03 AACC submitted comments to FDA regarding its draft statistical guidance for studies evaluating diagnostic tests
   
05/01/03 AACC submitted comments to CDC regarding its new Performance Evaluation Program for Rapid HIV Testing
   
04/29/03 AACC submitted comments to CMS regarding the interpretive guidelines for the revised CLIA quality systems standards
   
03/24/03 AACC wrote to Senator Lincoln endorsing S.599, the Access to Diabetes Screening Services Act of 2003
 
03/24/03 AACC wrote to Senator Dorgan endorsing S.382, the Medicare Cholesterol Screening Coverage Act of 2003
 
03/05/03 AACC wrote to Rep. Nancy Johnson endorsing H.R.877, the Patient Safety Improvement Act of 2003
 
01/30/03 AACC submitted comments to CMS regarding its inherent reasonableness interim final rule
Page Access: